Navigation Links
New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
Date:10/16/2007

NORTH BRUNSWICK, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Researchers testing a vaccine based on the live bacteria Listeria, in women with advanced cervical cancer found it to be safe. The Lovaxin C vaccine being developed by Advaxis Inc. (OTC Bulletin Board: ADXS), is intended to treat cervical cancer and head and neck cancers that result from the human papilloma virus (HPV). This marked the first time the vaccine had been treated in humans.

"Our long held belief that live Listeria vaccines are safe, even in end stage cancer patients, has been confirmed with the results from our recent Phase I/II study. We have just entered the age of safe bacterial therapies," said Dr. John Rothman, VP of Clinical Development.

The immune response that Listeria generates is called "cellular" immunity, the type needed to attack cancer. Listeria is one of the strongest stimulators of cellular immunity known. "By redirecting it against specific tumor types safely, we have created a new, and potentially very effective, class of cancer therapy," says Rothman.

Advaxis reported treating fifteen patients in three dosage groups with thirty-minute 250 ml infusions of Lovaxin C at three-week intervals. Patients were observed for a total of 111 days. With the exception of two women, all patients had had either stage IVb advanced, recurrent, or progressive cervical cancer.

Every patient experienced a flu-like syndrome in the three-to-twelve hours after dosing comprised of fever, chills, nausea, and occasional vomiting, which is consistent with immune stimulation. In the lower two doses, symptoms were well tolerated and resolved with the use of over the counter analgesics and antihistamines.

Although efficacy was not a primary focus of the trial, efficacy findings were obtained. Of the seven stable patients, three had reductions in their tumor mass subsequent to treatment. While most lesions increased in size, tumor reduction was seen in a number of lesions an
'/>"/>

SOURCE Advaxis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology ... cancer, announced today that Daniel P. Gold , Ph.D., ... th Annual Needham Healthcare Conference on Wednesday, April 15, ... Central Hotel in New York . A ... www.meipharma.com . A replay will be available approximately one hour ...
(Date:4/1/2015)... and WILMINGTON, N.C. , April 1, ... third among all CROs in the 2015 CenterWatch survey ... Chiltern,s high ranking, Susan Romberg , Vice President ... to say ,Thank You, to the all the clinical ... the benefits of specialization through having a deep understanding ...
(Date:4/1/2015)... -- Daiichi Sankyo, Inc., the US subsidiary of Daiichi Sankyo ... its US-based sister company, Asubio Pharmaceuticals, Inc.  As a ... the Daiichi Sankyo global development organization, led by ... Pharmaceuticals, parent company, Asubio Pharma Co., Ltd, which is ... to operate as a wholly owned subsidiary of Daiichi ...
Breaking Medicine Technology:MEI Pharma to Present at Needham Healthcare Conference 2Chiltern Ranks Among Top CROs In Global Survey Of Clinical Research Sites 2Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge 2
(Date:4/1/2015)... Patients with inoperable mesothelioma may soon have ... the FDA’s approval of CRS-207’s orphan drug application ... on the Surviving Mesothelioma website. , CRS-207 is ... the bacteria that causes the food-borne illness Listeriosis. The ... and other incentives to support continued testing and development ...
(Date:4/1/2015)... Denver, Colorado (PRWEB) April 01, 2015 ... a member of the American Cannabis Exchange and will ... ACE Marketplace. Native Roots joins the exchange as one ... holding sixty-eight licenses and operating fifteen stores in 9 ... 2015. , “We are excited to have ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 Eighty ... in athletics grants from California Casualty . Many ... or reduced-cost lunches and subsequently have fewer and fewer ... named after California Casualty Chairman Emeritus Thomas R. Brown, ... translated to the classroom. Since its inception in ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 The ... laboratory professionals are set to retire in the ... increased the demand for laboratory automation. The application ... importance as it ensures timely progress and efficiency ... adoption of lab automation in high-throughput screening, combinatorial ...
(Date:4/1/2015)... Rocky Mount, North Carolina (PRWEB) April 01, 2015 ... in-home care and assisted living placement counseling, recently opened a ... Carolina location. Amada franchise partners Tracy and Lee Bissett decided ... of the rights to the area after over 20 years ... be held on Thursday, April 2nd. , When ...
Breaking Medicine News(10 mins):Health News:Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 4Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 5Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 2Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 3Health News:Amada Senior Care Expands to Eastern North Carolina 2
... Sept. 17 New Jersey,hospitals demonstrated continued advances ... released today by the state Department of,Health and ... of hospitals, ongoing commitment to,healthcare quality. Hospitals statewide ... like the Robert Wood Johnson Foundation in a ...
... Residents to Eat Right, Move More and ... Milk Their ... by the ups and downs of different fad diets, but long-term success,has ... A new campaign crossing the country, the Campaign for Healthy Weight,is rallying ...
... Va., Sept. 17 Back to school time is ... in their child,s oral health,care. According to a study ... students miss more than 51 million school hours per ... can distract,your child, cause schoolwork to suffer or even ...
... have published a study showing that the degree of ... is what predicts poor mental and sexual health ... of attending an HIV prevention seminar, 422 Midwestern gay ... homosexuality, their degree of positive or negative attitudes towards ...
... OneTouch® Link,; USA-ONE Interactive offers Docuvation users full control of ... of paper documents all with a simple touch. , ... ... – www.USA-ONE.com [USA-ONE Interactive], leading reseller of Docuvation, ...
... pharmaceutical and biotech industries, and medical device companies will discuss ... and regulations, the Clinical Trials.gov registry, and results database during ... Disclosure: The Changing Tide (October 15-16; Chicago, IL). , ... ...
Cached Medicine News:Health News:NJHA: Hospitals Achieve Gains in Healthcare Quality, But Commitment to Improve Continues 2Health News:Message to North Carolina Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to North Carolina Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Smart Minds Start With Healthy Mouths 2Health News:Smart Minds Start With Healthy Mouths 3Health News:Homosexuals' negative feelings about sexuality predict poor mental and sexual health 2Health News:USA-ONE Interactive Unveils Visioneer OneTouch Scanning into the Docuvation Content Management Solution 2Health News:USA-ONE Interactive Unveils Visioneer OneTouch Scanning into the Docuvation Content Management Solution 3Health News:USA-ONE Interactive Unveils Visioneer OneTouch Scanning into the Docuvation Content Management Solution 4Health News:DIA Conference to Present Latest Strategies in Clinical Trial Disclosure Compliance 2
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
Test for AFP...
Ovarian Cancer Test...
Test for prostatic acid phosphatase...
Medicine Products: